Ottawa's push for lower drug costs may hurt patients, stunt innovation

Fox 40 TV (Canada)

“The federal government is potentially on a path that will limit access of Canadians to new life-saving drugs, while further discouraging the discovery of new medicines,” said Steven Globerman, professor emeritus at Western Washington University, Fraser Institute senior fellow and study co-author.

Click the heart to favorite

Your feedback is crucial to telling Western's story.
Thursday, January 24, 2019 - 9:49am

Share